ArticleCureus2024

Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects.

Rahman Ladak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.